Asklepios BioPharmaceutical Company
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Founded Date:
2001
Headquarters:
Chapel Hill, North Carolina, United States
Technology:
Neurological Disorders
Industry:
Gene Therapy
Estimated Revenue:
$10M to $50M
Funding Status:
M&A